Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk

Atherosclerosis

Volumn 214, Issue 1, 2011, Pages 39-40

  Kajinami, Kouji ^a   Kawai, Yasuyuki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biomarker; C reactive protein; Cardiovascular risk; Pregnancy associated plasma protein A

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; PLACEBO; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; HUMAN; INFLAMMATION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; RISK FACTORS;

EID: 78650836340     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.028     Document Type: Note

References (13)

1. Hlatky M.A., Greenland P., Arnett D.K., et al. American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416.
2. Corrado E., Rizzo M., Coppola G., et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010, 17:1-11.
3. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein a as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
4. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein predicts outcome in patients with acute coronary syndrome but no troponin i elevation. Circulation 2003, 108:1924-1926.
5. Heeschen C., Dimmeler S., Hamm C.W., et al. CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005, 45:229-237.
6. Cosin-Sales J., Christiansen M., Kaminski P., et al. Pregnancy-associated plasma protein a and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004, 109:1724-1728.
7. Cosin-Sales J., Kaski J.C., Christiansen M., et al. Relationship among pregnancy associated plasma protein-a levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005, 26:2093-2098.
8. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006, 27:1678-1684.
9. Consuegra-Sanchez L., Petrovic I., Cosin-Sales J., et al. Prognostic value of circulating pregnancy-associated plasma protein-a (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin Chim Acta 2008, 391:18-23.
10. Consuegra-Sanchez L., Fredericks S., Kaski J.C. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 2009, 203:346-352.
11. Iversen KK, Teisner B, Winkel P, et al. Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis; in press, doi:10.1016/j.atherosclerosis.2010.10.025.
12. Jespersen C.M., Als-Nielsen B., Damgaard M., et al. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR Trial. BMJ 2006, 332:22-27.
13. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G.D., Kremastinos D.T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008, 199:3-11.